Session 6: Drug Discovery of Alzheimer's Disease (AD), Parkinson's Disease (PD)and Related Aging Disorders
|
|
Title: Allosteric Potentiators of mGlu4 as a Novel Approach to Treatment of Parkinson's Disease
Dr. Jeffrey Conn, Director, Vanderbilt Medical Center, USA
|
|
Title: Synthesis and Development of Potent and Selective mGluR2/3 Agonists
Dr. Lushi Tan, Process research, Merck & Co., Inc., USA
|
|
Title: Title: Perspectives for Ginseng in Neurodegenerative Diseases
Dr. Rausch Wolf-Dieter, Professor, Institute of Medical Chemistry, Veterinary Medical University Vienna, Austria
|
|
Title: Targeting Inflammation in Parkinson's Disease : A Key Role for Glial-neuron Crosstalk
Dr. Bianca Marchetti, Professor of Clinical Pharmacology,University of Sassari Medical School, Lab Head, Neuropharmacology Session, OASI Inst. Troina (EN), Italy
|
|
Title: New Strategies in Stem Cell Transplantation and Growth Factor Application in Parkinson Disease
Dr. Marco Timmer, Hannover Medical School, Dept Neuroanatomy, Hannover, Germany
|
| |
Title: Anti-dementia Steroidal Saponins from Herbs
Dr. Baiping Ma, Vice President, Biotechnology Laboratory, Institute of Radiation Medicine, the Academy of Military Medical Sciences
|
| |
Title: Targeting Inflammation in Alzheimer Disease Role if Glial Cells in Neurodegeneration
Dr. Alicia Gonzalo-Ruiz, Professor, Valladolid University (Campus of Soria), Spain
|
| |
Title: A New Chinese Medicine (Memoregain?) for Antivascular Dementia
Dr. Muhuan Su, Executive Chair, Center of Drug Discovery, Sinphar Group, Taiwan, China
|
|
Home
